# Medical Facilities Corporation (DR.TO) fundamentals

Data as of 2026-09-08. TSX, Canada. Sector: Healthcare / Health Care Equipment & Supplies. Price C$15.42, market value C$250 million.

## Valuation
- **P/E (trailing): 12.1×** (5-yr avg 12.7×, 3-yr avg 13.5×). Medical Facilities Corporation trades at 12.1× trailing earnings, close to its own five-year average of 12.7×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 10.1×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 1.73**. A PEG of 1.73 is in the range usually read as fairly priced for its growth.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.9×**. The shares trade at 1.9× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 2.5×**. Enterprise value is 2.5× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 25.7%** (5-yr avg 22.2%). Free cash flow equals 25.7% of the market value, in line with its five-year average of 22.2%. Above 5% is generally attractive.
- **Earnings yield: 8.2%**. The inverse of the P/E: 8.2% of the price is earned each year.

## Profitability
- **Gross margin: 44.6%**. Medical Facilities Corporation keeps 44.6% of revenue after the direct cost of what it sells.
- **Operating margin: 17.8%**. 17.8% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 8.2%**. 8.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 28.0%**. 28.0% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 46.7%**. Return on all capital, debt included, is 46.7%: comfortably above what that capital costs.
- **Return on assets: 14.7%**. Each dollar of assets produces 14.7% of profit.

## Growth
- **Revenue growth (1 yr): -22.0%** (3-yr -15.2%/yr, 5-yr -6.6%/yr). Revenue fell 22.0% over the last year, against -6.6% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 5.8%** (3-yr 37.4%/yr, 5-yr -1.9%/yr). Earnings per share rose 5.8%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -6.6%/yr**. Free cash flow has compounded at -6.6% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.78**. Debt is 0.78 times equity, moderate leverage.
- **Net debt / EBITDA: 0.2×**. It would take 0.2 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 37.4×**. Operating profit covers interest 37.4× over, a safe margin.
- **Current ratio: 1.79** (quick 1.70). Current assets cover the next year's liabilities 1.79 times.
- **Altman Z-score: 3.02**. A Z-score of 3.02 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 2.33%** (C$0.36 per share, trailing). Medical Facilities Corporation yields 2.33%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 25%** (11% of free cash flow). 25% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 5**. 5 straight years of increases.
- **Dividend growth (5 yr): 5.2%/yr** (1-yr 2.6%). The dividend has grown 5.2% a year over five years.
- **Shareholder yield: 20.8%**. Dividends plus net buybacks return 20.8% of the market value a year.

## Price and momentum
- **Total return (1 yr): 6.8%** (YTD -1.8%, 3-mo -16.3%). The shares are up 6.8% over twelve months including dividends.
- **From 52-week high: -17.9%** (13.5% above the low). Trading 18% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 39**. An RSI of 39 is neutral.
- **Beta (1 yr): 0.33** (volatility 26%). Beta of 0.33 against the S&P/TSX Composite: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=DR.TO · Page: https://foliofundamentals.com/stocks/dr.to

Not investment advice.